At the same time, a phase 3 clinical trial in ALS patients using Arimoclomol74, which is a related HSP70 inducer that had shown promise in preclinical mouse models, was terminated as it did not lead to measurable efficacy outcomes75,76. The gene discussed is HSPA1A; the disease is amyotrophic lateral sclerosis.